Next Generation Heart Disease Modeling & Drug Discovery/Screening
Next-Generation Heart Disease Modeling & Drug Discovery/Screening
Reduce Cost, Cut Time, Improve Efficacy and Safety
Novoheart is a
global stem cell biotechnology
company dedicated to
engineering bioartificial human heart surrogates
using state-of-the-art bioengineering approaches.
The impact of what Novoheart has been able to put forward cannot be understated. Our team of scientists is pioneering a new way forward for bioartificial heart tissue and organ modeling. The numbers below trumpet our success.
1st
1st
3
25+
100+
12+
Our Products
Evaluating the state of cardiac health requires extensive assessment of a diverse set of functional outputs. Novoheart’s mini-Heart Platform is the ideal solution, consisting of 3 advanced engineered-tissue formats fabricated from human stem cell-derived cardiomyocytes that are designed for assessing specific cardiac functional outputs. Data acquired by the mini-Heart Platform has successfully led to a series of pre-clinical candidates as well as Investigational New Drug (IND) applications and clinical trials.
View the video clip for a quick summary of Novoheart’s
game changing mini-Heart Platform.